The emerging role of phosphate in vascular calcification

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Cell Biology

Background:

• Vascular calcification is a significant factor in cardiovascular disease (CVD) mortality among end-stage renal disease (ESRD) patients.
• Hyperphosphatemia, a common condition in ESRD, is a key inducer of vascular calcification.
• Genetic factors and regulatory molecules influence an individual's susceptibility to vascular calcification.

Purpose of the Study:

• To elucidate the role of hyperphosphatemia and sodium-dependent phosphate cotransporters in vascular calcification in ESRD.
• To understand how disease states and cytokines affect vascular smooth muscle cell (SMC) susceptibility to calcification.

Main Methods:

• Investigated the response of vascular smooth muscle cells (SMCs) to elevated phosphate levels.
• Focused on the mechanism involving sodium-dependent phosphate cotransporters in SMCs.
• Examined the impact of disease states and cytokines on cotransporter expression.

Main Results:

• Elevated phosphate levels induce an osteochondrogenic phenotype change in SMCs.
• SMCs mineralize extracellular matrix via sodium-dependent phosphate cotransporters.
• Increased cotransporter expression in SMCs enhances calcification susceptibility, even at normal phosphate concentrations.

Conclusions:

• Hyperphosphatemia is a critical, non-traditional risk factor for CVD mortality in ESRD patients.
• Sodium-dependent phosphate cotransporters are key mediators of vascular calcification in response to phosphate.
• Modulating cotransporter activity may offer therapeutic strategies to prevent vascular calcification in ESRD.